Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Combivir approved in E.U.

March 19, 1998

Stavudine versus zidovudine therapy in HIV-1-infected pediatric patients

March 18, 1998

AIDS patients will have expanded access to Ziagen

March 17, 1998

Fortovase cited as preferred therapy in AIDS guidelines

March 17, 1998

p24-VLP safe but not immunogenic in phase II trials

March 17, 1998

Cel-Sci on the way to developing a worldwide AIDS vaccine

March 13, 1998

European academics collaborate on R&D of novel NNRTIs

March 12, 1998

Oxandrin approved in Russia

March 12, 1998

DynaGen allowed U.S. patent for ImmuDyn HIV/AIDS use

March 12, 1998

Crixivan gets traditional FDA approval

March 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...